Trial intelligence / Profile preview

Fluoride and combination varnishes for white spot lesions in children with ECC

NCT03360266Completed

Sponsor
Indira Gandhi Institute of Dental Sciences
Start
Mar 2016
Primary completion
Dec 2016
Modality
Nanoparticles, DNA Intercalators/Alkylators
01

Overview

Randomised, double-blind trial of sodium fluoride, amorphous calcium phosphate and casein phosphopeptide-amorphous calcium phosphate in early childhood caries (ECC) and White spot lesion (WSL), sponsored by Indira Gandhi Institute of Dental Sciences. Started Mar 2016; status: completed.

02

Drugs

sodium fluorideamorphous calcium phosphatecasein phosphopeptide-amorphous calcium phosphate
03

Conditions

early childhood caries (ECC)White spot lesion (WSL)

Beyond the preview

Go deeper on NCT03360266.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03360266.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call